glutathione pathway to triple negative cancer The crosstalk between metabolism and non-coding RNAs in progression and treatment resistance Cysteine metabolic circuitries: druggable targets
Cysteine metabolic circuitries: druggable targets in cancer British Journal of Cancer Ferroptosis heterogeneity in triple negative breast cancer reveals an innovative immunotherapy combination strategy ScienceDirect Glutathione Synthesis in Cancer Cells Biochemistry (Moscow) Springer Nature Link NRF2 activation by cysteine as a survival mechanism for triple negative breast cancer cells Oncogene
Pay in 4 interest-free payments of $6.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25



